The study of rheumatic diseases that affect children has thrived in the past 10 years. A look at several important advances in this area illustrates how organized collaborations and advanced technologies are contributing to the understanding and, ultimately, to improving the treatment of these disorders.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Zhou, Q. et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N. Engl. J. Med. 370, 911–920 (2014).
Wakil, S. M. et al. Association of a mutation in LACC1 with a monogenic form of systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 67, 288–295 (2015).
Pascual, V. et al. How the study of children with rheumatic diseases identified interferon-α and interleukin-1 as novel therapeutic targets. Immunol. Rev. 223, 39–59 (2008).
Toplak, N. et al. An international registry on autoinflammatory diseases: the Eurofever experience. Ann. Rheum. Dis. 71, 1177–1182 (2012).
Crow, Y. J. & Manel, N. Aicardi-Goutières syndrome and the type I interferonopathies. Nat. Rev. Immunol. 15, 429–440 (2015).
Hinks, A. et al. Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat. Genet. 45, 664–669 (2013).
Wehrens, E. J., Prakken, B. J. & van Wijk, F. T cells out of control—impaired immune regulation in the inflamed joint. Nat. Rev. Rheumatol. 9, 34–42 (2013).
Zulian, F. et al. The Pediatric Rheumatology European Society/American College of Rheumatology/European League Against Rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum. 57, 203–212 (2007).
Ozen, S. et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann. Rheum. Dis. 69, 798–806 (2010).
Rothmund, F. Validation of relapse risk biomarkers for routine use in patients with juvenile idiopathic arthritis. Arthritis Care Res. (Hoboken) 66, 949–955 (2014).
Acknowledgements
The author apologizes to colleagues whose work could not be cited because of space constraints.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares that she has acted as a consultant for Novartis and received speaker honoraria from Roche and Sobi.
Supplementary information
Supplementary Box 1
Additional reading. (DOCX 22 kb)
Rights and permissions
About this article
Cite this article
Ozen, S. A field on the move. Nat Rev Rheumatol 11, 625–626 (2015). https://doi.org/10.1038/nrrheum.2015.130
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2015.130
